Cargando…

Novel Thienopyrimidine-Based PET Tracers for P2Y(12) Receptor Imaging in the Brain

[Image: see text] The P2Y(12) receptor (P2Y(12)R) is uniquely expressed on microglia in the brain, and its expression level directly depends on the microglial activation state. Therefore, P2Y(12)R provides a promising imaging marker for distinguishing the pro- and anti-inflammatory microglial phenot...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Wildt, Berend, Janssen, Bieneke, Pekošak, Aleksandra, Stéen, E. Johanna L., Schuit, Robert C., Kooijman, Esther J. M., Beaino, Wissam, Vugts, Danielle J., Windhorst, Albert D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640995/ https://www.ncbi.nlm.nih.gov/pubmed/34757711 http://dx.doi.org/10.1021/acschemneuro.1c00641

Ejemplares similares

Correction to Novel Thienopyrimidine-Based PET Tracers for P2Y(12) Receptor Imaging in the Brain
por: van der Wildt, Berend, et al.
Publicado: (2022)

Towards PET imaging of the dynamic phenotypes of microglia
por: Beaino, Wissam, et al.
Publicado: (2021)

Synthesis and Preclinical Evaluation of the First Carbon-11 Labeled PET Tracers Targeting Substance P(1–7)
por: Pekošak, Aleksandra, et al.
Publicado: (2018)

Synthesis and Preclinical Evaluation of [Methylpiperazine-(11)C]brigatinib as a PET Tracer Targeting Both Mutated Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase
por: Högnäsbacka, Antonia A., et al.
Publicado: (2023)

PET imaging of P2X(7)R in the experimental autoimmune encephalomyelitis model of multiple sclerosis using [(11)C]SMW139
por: Beaino, Wissam, et al.
Publicado: (2020)

In vivo evaluation of two tissue transglutaminase PET tracers in an orthotopic tumour xenograft model
por: van der Wildt, Berend, et al.
Publicado: (2018)

PET Imaging of Microglial Activation—Beyond Targeting TSPO
por: Janssen, Bieneke, et al.
Publicado: (2018)

Identification of the allosteric P2X(7) receptor antagonist [(11)C]SMW139 as a PET tracer of microglial activation
por: Janssen, Bieneke, et al.
Publicado: (2018)

The P2X(7) receptor tracer [(11)C]SMW139 as an in vivo marker of neuroinflammation in multiple sclerosis: a first-in man study
por: Hagens, Marloes H. J., et al.
Publicado: (2019)

State of the art procedures towards reactive [(18)F]fluoride in PET tracer synthesis
por: Haveman, Lizeth Y. F., et al.
Publicado: (2023)

Performance of nanoScan PET/CT and PET/MR for quantitative imaging of (18)F and (89)Zr as compared with ex vivo biodistribution in tumor-bearing mice
por: Chomet, Marion, et al.
Publicado: (2021)

Purinergic receptors P2Y12R and P2X7R: potential targets for PET imaging of microglia phenotypes in multiple sclerosis
por: Beaino, Wissam, et al.
Publicado: (2017)

Advancing (89)Zr-immuno-PET in neuroscience with a bispecific anti-amyloid-beta monoclonal antibody - The choice of chelator is essential
por: Wuensche, Thomas E., et al.
Publicado: (2022)

Alpha-Synuclein PET Tracer Development—An Overview about Current Efforts
por: Korat, Špela, et al.
Publicado: (2021)

Pretargeted PET Imaging with a TCO-Conjugated Anti-CD44v6 Chimeric mAb U36 and [(89)Zr]Zr-DFO-PEG(5)-Tz
por: Lumen, Dave, et al.
Publicado: (2022)

Identification of new molecular targets for PET imaging of the microglial anti-inflammatory activation state
por: Villa, Alessandro, et al.
Publicado: (2018)

The Development of Positron Emission Tomography Tracers for In Vivo Targeting the Kinase Domain of the Epidermal Growth Factor Receptor
por: Högnäsbacka, Antonia, et al.
Publicado: (2022)

Immuno-PET Imaging of Atherosclerotic Plaques with [(89)Zr]Zr-Anti-CD40 mAb—Proof of Concept
por: Poels, Kikkie, et al.
Publicado: (2022)

Imaging the TGFβ type I receptor in pulmonary arterial hypertension
por: Rotteveel, Lonneke, et al.
Publicado: (2023)

Head-to-head comparison of DFO* and DFO chelators: selection of the best candidate for clinical (89)Zr-immuno-PET
por: Chomet, Marion, et al.
Publicado: (2020)

Application of (89)Zr-DFO*-immuno-PET to assess improved target engagement of a bispecific anti-amyloid-ß monoclonal antibody
por: Stergiou, N., et al.
Publicado: (2023)

Thienopyrimidine: A Promising Scaffold to Access Anti-Infective Agents
por: Lagardère, Prisca, et al.
Publicado: (2021)

Novel Thienopyrimidine Inhibitors of Leishmania N-Myristoyltransferase with On-Target Activity in Intracellular Amastigotes
por: Bell, Andrew S., et al.
Publicado: (2020)

Synthesis and preliminary preclinical evaluation of fluorine-18 labelled isatin-4-(4-methoxyphenyl)-3-thiosemicarbazone ([(18)F]4FIMPTC) as a novel PET tracer of P-glycoprotein expression
por: Verbeek, Joost, et al.
Publicado: (2018)

Thienopyrimidine Derivatives as GPR55 Receptor Antagonists: Insight into Structure–Activity Relationship
por: Figuerola-Asencio, Laura, et al.
Publicado: (2022)

In Silico Screening and Anticancer-Apoptotic Evaluation of Newly Synthesized Thienopyrimidine/Sulfonamide Hybrids
por: Elmongy, Elshaymaa I., et al.
Publicado: (2023)

Synthesis and Evaluation of New Fluorine-18 Labeled Verapamil Analogs To Investigate the Function of P-Glycoprotein in the Blood–Brain Barrier
por: Raaphorst, Renske M., et al.
Publicado: (2017)

PET imaging with radiolabeled antibodies and tyrosine kinase inhibitors: immuno-PET and TKI-PET
por: van Dongen, Guus A. M. S., et al.
Publicado: (2012)

Synthesis of Novel Biocompatible Thienopyrimidine Chromophores with Aggregation-Induced Emission Sensitive to Molecular Aggregation
por: Ahmed, Mostafa, et al.
Publicado: (2020)

Imidazoline-I2 PET Tracers in Neuroimaging
por: Parker, Christine A., et al.
Publicado: (2023)

Strategies towards in vivo imaging of active transglutaminase type 2 using positron emission tomography
por: van der Wildt, Berend, et al.
Publicado: (2016)

Design, Synthesis, and Biological Evaluation of Novel Thienopyrimidine Derivatives as PI3Kα Inhibitors
por: Yu, Lide, et al.
Publicado: (2019)

Synthesis and biological evaluation of novel thienopyrimidine derivatives as diacylglycerol acyltransferase 1 (DGAT-1) inhibitors
por: Hong, Dong Jin, et al.
Publicado: (2019)

PET Tracers for Clinical Imaging of Breast Cancer
por: Peñuelas, Iván, et al.
Publicado: (2012)

Imaging and Methotrexate Response Monitoring of Systemic Inflammation in Arthritic Rats Employing the Macrophage PET Tracer [(18)F]Fluoro-PEG-Folate
por: Chandrupatla, Durga M. S. H., et al.
Publicado: (2018)

Beyond FDG: novel PET tracers for cancer imaging
por: Hicks, Rodney J
Publicado: (2003)

Application of PET Tracers in Molecular Imaging for Breast Cancer
por: Boers, Jorianne, et al.
Publicado: (2020)

PET tracer development—a tale of mice and men
por: Hicks, Rodney J, et al.
Publicado: (2006)

Synthesis and bioevaluation of thienopyrimidines bearing a pyrazoline unit as selective PI3Kα inhibitors
por: Lai, Luogen, et al.
Publicado: (2019)

Quantification of [(18)F]florbetapir: A test–retest tracer kinetic modelling study
por: Golla, Sandeep SV, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rikl40kdimikp0a829ltd7gp8t